Furthermore, the influences of DLGAP1-AS1 knockdown on proliferation, migration, apoptosis and EMT-related factors were rescued by overexpression of miR-26a/b-5p inhibitors or IL-6 treatment, indicating the ceRNA network concerning DLGAP1-AS1, miR-26a/b-5p and IL-6 in HCC cells. This evidence concerns the gene DLGAP1 and hepatocellular carcinoma.